Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: A retrospective study of the veterans affairs healthcare system-Reference-Cited by-同舟云学术

Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: A retrospective study of the veterans affairs healthcare system

Published:2014-05 Issue:5 Volume:9 Page:289-296
ISSN:1553-5592
Container-title:Journal of Hospital Medicine
language:en
Short-container-title:J. Hosp. Med.

Author:

Mudumbai Seshadri C.¹,Takemoto Steven²,Cason Brian A.²,Au Selwyn³,Upadhyay Anjali⁴,Wallace Arthur W.²

Affiliation:

1. Anesthesia Service, Veterans Affairs Palo Alto Health Care System, Palo Alto and Department of Anesthesiology, Perioperative, and Pain Medicine; Stanford University; Stanford California

2. Anesthesia Service, Veterans Affairs Medical Center, San Francisco, and Department of Anesthesiology and Perioperative Care; University of California; San Francisco California

3. Cooperative Studies Program Coordinating Center, Veterans Affairs Palo Alto Health Care System; Palo Alto California

4. Health Economics Resource Center,Veterans Affairs Palo Alto Health Care System; Palo Alto California

Publisher

Wiley

Subject

Assessment and Diagnosis,Care Planning,Health Policy,Fundamentals and skills,General Medicine,Leadership and Management

Link

https://cdn.mdedge.com/files/s3fs-public/pdfs/journals/jhm2182.pdf

Reference40 articles.

1. The development of polypharmacy;Veehof;A longitudinal study. Fam Pract,2000

2. Polypharmacy in a general surgical unit and consequences of drug withdrawal;Kennedy;Br J Clin Pharmacol,2000

3. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients;Shammash;Am Heart J,2001